Clinical trial · Observational
A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness of Sublobar Dissection in the Chinese Patients With Non-small Cell Lung Cancer
NCT03427567CI-TRIAL-00033018completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A study to evaluate effectiveness of sublobar dissection in patients with non-small cell lung cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Sublobar dissection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Sublobar dissection
- description
- Chinese NSCLC patients who received sublobar dissection
- interventionNames
- Procedure: Sublobar dissection
Primary outcomes (1)
- measure
- Overall survival
- timeFrame
- 2014 - 2017
- description
- Overall survival
Secondary outcomes (1)
- measure
- Overall survivals in subgroups
- timeFrame
- 2014 - 2017
- description
- Overall survivals categorised by tumor biological characteristics
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients \>= 18 years old; * Patients who received sublobar dissection from 2014 to 2017 (segment dissection/wedge dissection/segment and wedge dissections); * Patients who received selective or systematic lymphadenectomy; * Pathologically diagnosed patients with non-small cell lung cancer; * Pathological staging: I, II Exclusion Criteria: * Patients who received cancer treatments before surgeries (adjuvant therapies including chemotherapies, radiotherapies, target therapies); * Patients who received late-phase or intolerant palliative lobectomy or compromise sublobar dissection;
References
Publications (0)
Data not yet available
No reference posted for this study.